Increased airway glucose increases airway bacterial load in hyperglycaemia

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Gill, Simren K ^a   Hui, Kailyn ^a   Farne, Hugo ^a   Garnett, James P ^b,c   Baines, Deborah L ^b   Moore, Luke S P ^a   Holmes, Alison H ^a   Filloux, Alain ^a   Tregoning, John S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ANIMAL; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL LOAD; BLOOD; COMPLICATION; CRITICAL ILLNESS; DISEASE MODEL; FEMALE; GENE DELETION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MOUSE; MUTATION; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTION;

ADULT; AGED; ANIMALS; BACTERIAL INFECTIONS; BACTERIAL LOAD; BLOOD GLUCOSE; CRITICAL ILLNESS; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; GENES, BACTERIAL; GLUCOSE; HUMANS; HYPERGLYCEMIA; MICE; MIDDLE AGED; MUTATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTIONS;

EID: 84974621029     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27636     Document Type: Article

References (31)

1. Baker, E. et al. Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis. J. Appl physiol (Bethesda, Md.: 1985) 102, 1969-1975, doi: 10.1152/japplphysiol.01425.2006 (2007).
2. Philips, B. et al. Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients. Thorax 60, 761-764, doi: 10.1136/thx.2004.035766 (2005).
3. Baker, E. H. et al. Hyperglycaemia and pulmonary infection. Proc.Nutr.Soc. 65, 227-235, http://dx.doi.org/10.1079/PNS2006499 (2006).
4. Rueda, A. M. et al. Hyperglycemia in diabetics and non-diabetics: Effect on the risk for and severity of pneumococcal pneumonia. J Infect 60, 99-105, http://dx.doi.org/10.1016/j.jinf.2009.12.003 (2010).
5. Philips, B., Meguer, J.-X., Redman, J. & Baker, E. Factors determining the appearance of glucose in upper and lower respiratory tract secretions. ICM 29, 2204-2210, doi: 10.1007/s00134-003-1961-2 (2003).
6. Pezzulo, A. et al. Glucose depletion in the airway surface liquid is essential for sterility of the airways. PloS one 6, e16166, doi: 10.1371/journal.pone.0016166 (2011).
7. Kalsi, K. K. et al. Apical and basolateral localisation of GLUT2 transporters in human lung epithelial cells. Pflugers Arch 456, 991-1003, doi: 10.1007/s00424-008-0459-8. (2008).
8. Garnett, J. et al. Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose. Thorax. 68, 835-45, doi: 10.1136/thoraxjnl-2012-203178 (2013).
9. Garnett, J. P. et al. Elevated paracellular glucose flux across cystic fibrosis airway epithelial monolayers is an important factor for Pseudomonas aeruginosa growth. PloS one 8, e76283, doi: 10.1371/journal.pone.0076283 (2013).
10. Williams, B., Dehnbostel, J. & Blackwell, T. Pseudomonas aeruginosa: Host defence in lung diseases. Respirology 15, 1037-1056, doi: 10.1111/j.1440-1843.2010.01819.x (2010).
11. Van Den Berg, J. M., Kouwenberg, J. M. & Heijerman, H. G. Demographics of glucose metabolism in cystic fibrosis. J Cyst Fibros 8, 276-279, doi: 10.1016/j.jcf.2009.04.010 (2009).
12. Silby, M., Winstanley, C., Godfrey, S., Levy, S. & Jackson, R. Pseudomonas genomes: Diverse and adaptable. FEMS microbiol rev 35, 652-680, doi: 10.1111/j.1574-6976.2011.00269.x (2011).
13. Mathee, K. et al. Dynamics of Pseudomonas aeruginosa genome evolution. PNAS, 105, 3100-3105, doi: 10.1073/pnas.0711982105 (2008).
14. Nguyen, D. & Singh, P. Evolving stealth: Genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. PNAS, 103, 8305-8306, doi: 10.1073/pnas.0602526103 (2006).
15. Winsor, G. L. et al. Pseudomonas Genome Database: Improved comparative analysis and population genomics capability for Pseudomonas genomes. NAR, 39, D596-600, doi: 10.1093/nar/gkq869 (2011).
16. Deeds, M. C. et al. Single dose streptozotocin-induced diabetes: Considerations for study design in islet transplantation models. Laboratory animals 45, 131-140, doi: 10.1258/la.2010.010090 (2011).
17. Mancuso, P. et al. Leptin-Deficient Mice Exhibit Impaired Host Defense in Gram-Negative Pneumonia. J Immunol 168, 4018-4024, doi: 10.4049/jimmunol.168.8.4018 (2002).
18. WHO & IDF. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Report of a WHO/IDF consultation. http://www.who.int/diabetes/publications/diagnosis-diabetes2006/en/(2006).
19. Ruer, S., Stender, S., Filloux, A. & De Bentzmann, S. Assembly of fimbrial structures in Pseudomonas aeruginosa: Functionality and specificity of chaperone-usher machineries. J bacteriol 189, 3547-3555, doi: 10.1128/JB.00093-07 (2007).
20. Valentini, M. & Lapouge, K. Catabolite repression in Pseudomonas aeruginosa PAO1 regulates the uptake of C4-dicarboxylates depending on succinate concentration. Envi microbiol 15, 1707-1716, doi: 10.1111/1462-2920.12056 (2013).
21. Kim, H. J. et al. Mutation in the edd gene encoding the 6-phosphogluconate dehydratase of Pseudomonas chlororaphis O6 impairs root colonization and is correlated with reduced induction of systemic resistance. Lett Appl Microbiol 44, 56-61, doi: 10.1111/j.1472-765X.2006.02029.x (2007).
22. Krismer, B. et al. Nutrient limitation governs Staphylococcus aureus metabolism and niche adaptation in the human nose. PLoS pathogens 10, e1003862, doi: 10.1371/journal.ppat.1003862 (2014).
23. Vandanmagsar, B. et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nature medicine 17, 179-188, doi: 10.1038/nm.2279 (2011).
24. Pezzulo, A. et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 487, 109-113, doi: 10.1038/nature11130 (2012).
25. Lee, R. J. et al. Bitter and sweet taste receptors regulate human upper respiratory innate immunity. JCI 124, 1393-1405, doi: 10.1172/JCI72094 (2014).
26. Reading, P. C., Allison, J., Crouch, E. C. & Anders, E. M. Increased Susceptibility of Diabetic Mice to Influenza Virus Infection: Compromise of Collectin-Mediated Host Defense of the Lung by Glucose? J Virol 72, 6884-6887, doi: Http://jvi.asm.org/content/72/8/6884 (1998).
27. Hodgson, K. et al. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunol 144, 171-185, doi: 10.1111/imm.12394 (2014).
28. Hitchings, A. W., Archer, J. R., Srivastava, S. A. & Baker, E. H. Safety of Metformin in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Diabetes Mellitus. COPD 2, 126-131, doi: 10.3109/15412555.2014.898052 (2014).
29. Holloway, B. W. Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol 13, 572-581, doi: 10.1099/00221287-13-3-572 (1955).
30. Kalsi, K. et al. Glucose homeostasis across human airway epithelial cell monolayers: Role of diffusion, transport and metabolism. Pflugers Arch 457, 1061-1070, doi: 10.1007/s00424-008-0576-4 (2009).
31. Siggins, M. K. et al. PHiD-CV induces anti-Protein D antibodies but does not augment pulmonary clearance of nontypeable Haemophilus influenzae in mice. Vaccine 33, 4954-4961, doi: 10.1016/j.vaccine.2015.07.034 (2015).